# Chugai Pharmaceutical Co., Ltd. (CHGCY)

> Source: Nexqual · https://nexqual.com/CHGCY · data as of 2026-10-23 17:07 UTC · cite as "Nexqual, Chugai Pharmaceutical Co., Ltd. (CHGCY), nexqual.com/CHGCY" · informational, not investment advice.

**Price:** USD 21.56 (+1.89% today) · US market open, as of October 23, 2026 at 17:07 UTC; quotes may be delayed. Prev close 21.16 · day 21.36–21.57 · 52w 18.33–34.84 · market cap $71.0B · PNK

## Key facts
- Analysts: None.
- Total return with dividends: 1Y -8.5% vs S&P 500 +14.4%; 5Y +18.4% vs S&P 500 +77.0%.
- Next earnings: 2026-10-27, EPS estimate USD —, revenue estimate $349B.

## Analysts
Consensus None.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-23) | 5Y (from 2021-10-25) |
|---|---|---|
| Total return | -8.5% | +18.4% |
| S&P 500 (SPY) | +14.4% | +77.0% |
| Per year | -8.5% | +3.5% |
| Volatility (annualized) | 39.9% | 34.5% |
| Max drawdown | -43.2% (Feb 2026→Oct 2026) | -43.2% (Feb 2026→Sep 2026) |

## Peers (Drug Manufacturers - General)
SNY (Sanofi) USD 41.5 -1.11% · GSK (GSK plc) USD 50.63 -1.13% · BMY (Bristol-Myers Squibb Company) USD 61.55 -2.30% · BIIB (Biogen Inc.) USD 250.37 -1.37% · PFE (Pfizer, Inc.) USD 29.98 -1.46% · NVO (Novo Nordisk A/S) USD 39.02 -1.04%

## More
Full page: https://nexqual.com/CHGCY · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends 2026-09-30) | — | — | — | $349.46B | — |
| Next quarter (ends 2026-12-31) | — | — | — | $369.19B | — |
| Current fiscal year (ends 2026-12-31) | — | — | — | $1.38T | — |
| Next fiscal year (ends 2027-12-31) | — | — | — | $1.52T | — |